Lewis JP

References (3)

Title : Randomized evaluation of the loss-of-function carboxylesterase 1 (CES1) G143E variant on clopidogrel and ticagrelor pharmacodynamics - Lewis_2024_Clin.Transl.Sci_17_e70079
Author(s) : Lewis JP , Ryan KA , Streeten EA , Whitlatch HB , Daue M , Tanner K , Perry JA , O'Connell JR , Shuldiner AR , Mitchell BD
Ref : Clin Transl Sci , 17 :e70079 , 2024
Abstract :
PubMedSearch : Lewis_2024_Clin.Transl.Sci_17_e70079
PubMedID: 39576732

Title : Genome-wide analysis of clopidogrel active metabolite levels identifies novel variants that influence antiplatelet response - Backman_2017_Pharmacogenet.Genomics_27_159
Author(s) : Backman JD , O'Connell JR , Tanner K , Peer CJ , Figg WD , Spencer SD , Mitchell BD , Shuldiner AR , Yerges-Armstrong LM , Horenstein RB , Lewis JP
Ref : Pharmacogenet Genomics , 27 :159 , 2017
Abstract :
PubMedSearch : Backman_2017_Pharmacogenet.Genomics_27_159
PubMedID: 28207573

Title : The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response - Lewis_2013_Pharmacogenet.Genomics_23_1
Author(s) : Lewis JP , Horenstein RB , Ryan K , O'Connell JR , Gibson Q , Mitchell BD , Tanner K , Chai S , Bliden KP , Tantry US , Peer CJ , Figg WD , Spencer SD , Pacanowski MA , Gurbel PA , Shuldiner AR
Ref : Pharmacogenet Genomics , 23 :1 , 2013
Abstract :
PubMedSearch : Lewis_2013_Pharmacogenet.Genomics_23_1
PubMedID: 23111421
Gene_locus related to this paper: human-CES1